Net Debt Summary of DV Biomed Co., Ltd.

DV Biomed Co., Ltd.'s latest annual net debt in 2023 was 160.7 Million TWD , up 1557.56% from previous year.
DV Biomed Co., Ltd.'s latest quarterly net debt in 2024 Q2 was -197.09 Million TWD , down 0.0% from previous quarter.
DV Biomed Co., Ltd. reported annual net debt of 9.69 Million TWD in 2022, up 102.91% from previous year.
DV Biomed Co., Ltd. reported annual net debt of -333.52 Million TWD in 2021, down -17.64% from previous year.
DV Biomed Co., Ltd. reported quarterly net debt of -197.09 Million TWD for 2024 Q1, down -222.65% from previous quarter.
DV Biomed Co., Ltd. reported quarterly net debt of 160.7 Million TWD for 2023 Q4, up 81.06% from previous quarter.

Annual Net Debt Chart of DV Biomed Co., Ltd. (2023 - 2019)

Name	Net Debt	Net Debt Difference
Allied Biotech Corporation	178.11 Million TWD	9.776%
GeneFerm Biotechnology Co., Ltd.	31.92 Million TWD	-403.352%
Easywell Biomedicals, Inc.	123.43 Million TWD	-30.188%
TTY Biopharm Company Limited	-705.97 Million TWD	122.763%
Synmosa Biopharma Corporation	1.52 Billion TWD	89.437%
Orient EuroPharma Co., Ltd.	3.1 Billion TWD	94.827%
Center Laboratories, Inc.	3.91 Billion TWD	95.9%
Tien Liang BioTech Co., Ltd.	-57.55 Million TWD	379.206%
Orient Pharma Co., Ltd.	633.6 Million TWD	74.637%
InnoPharmax Inc.	-17.85 Million TWD	999.877%
Johnson Chemical Pharmaceutical Works Co., Ltd.	-926.77 Million TWD	117.34%
Excelsior Biopharma Inc.	-212.51 Million TWD	175.619%
Foresee Pharmaceuticals Co., Ltd.	-781.42 Million TWD	120.565%
Handa Pharmaceuticals, Inc.	-653.8 Million TWD	124.579%
UniPharma Co., Ltd.	-68.36 Million TWD	335.055%
Anxo Pharmaceutical Co., Ltd.	492.4 Million TWD	67.364%
Alar Pharmaceuticals Inc.	-738.05 Million TWD	121.773%
Winston Medical Supply Co., Ltd.	-191.81 Million TWD	183.781%
Mercury Biopharmaceutical Corporation	-1.94 Million TWD	8362.211%
Bioray Biotech Co., Ltd	-27.23 Million TWD	690.115%
TSH Biopharm Corporation Limited	-568.74 Million TWD	128.255%